Current Development of Pyrazole–Azole Hybrids With Anticancer Potential
Future Medicinal Chemistry · 2023-08 · 15 (16) · 1527-1548
DOI: 10.4155/fmc-2023-0138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 23.08.2023. Verfasst von Shu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Pollution Damage Assessment & Environmental Health Risk Prevention & Control, Hubei Provincial Academy of Eco-Environmental S…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Pollution Damage Assessment & Environmental Health Risk Prevention & Control, Hubei Provincial Academy of Eco-Environmental Sciences, Wuhan, Hubei, 430000, PR China.
- Technical Review Center for Administrative Licensing, Hubei Provincial Administration for Market Regulation, Wuhan, Hubei, 430000, PR China.
ORCID-Profile: Shu Zhang
Zitieren
APA
Zhang, S., Ye, Y., Zhang, Q., Luo, Y., Wang, Z. C., Wu, Y. Z., Zhang, X. P., & Yi, C. (2023). Current Development of Pyrazole–Azole Hybrids With Anticancer Potential. Future Medicinal Chemistry, 15(16), 1527-1548. https://doi.org/10.4155/fmc-2023-0138
Vancouver
Zhang S, Ye Y, Zhang Q, Luo Y, Wang ZC, Wu YZ, et al. Current Development of Pyrazole–Azole Hybrids With Anticancer Potential. Future Medicinal Chemistry. 2023;15(16):1527-1548. doi:10.4155/fmc-2023-0138
BibTeX
@article{Zhang2023,
author = {Zhang, Shu and Ye, Yun and Zhang, Qiang and Luo, Yang and Wang, Zi-Chen and Wu, Yi-Zhe and Zhang, Xiang-Pu and Yi, Chuan},
title = {Current Development of Pyrazole–Azole Hybrids With Anticancer Potential},
journal = {Future Medicinal Chemistry},
year = {2023},
volume = {15},
number = {16},
pages = {1527--1548},
doi = {10.4155/fmc-2023-0138}
}
EUVIMED